Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs SYSCHEM (I). - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA SYSCHEM (I). AUROBINDO PHARMA/
SYSCHEM (I).
 
P/E (TTM) x 23.0 70.2 32.7% View Chart
P/BV x 2.4 10.7 22.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AUROBINDO PHARMA   SYSCHEM (I).
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
SYSCHEM (I).
Mar-23
AUROBINDO PHARMA/
SYSCHEM (I).
5-Yr Chart
Click to enlarge
High Rs71565 1,097.7%   
Low Rs39711 3,544.2%   
Sales per share (Unadj.) Rs424.230.3 1,398.4%  
Earnings per share (Unadj.) Rs32.91.4 2,324.7%  
Cash flow per share (Unadj.) Rs54.12.3 2,392.6%  
Dividends per share (Unadj.) Rs3.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs458.17.0 6,549.1%  
Shares outstanding (eoy) m585.9431.89 1,837.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.3 104.2%   
Avg P/E ratio x16.927.0 62.7%  
P/CF ratio (eoy) x10.316.9 60.9%  
Price / Book Value ratio x1.25.5 22.2%  
Dividend payout %9.10-   
Avg Mkt Cap Rs m325,7531,217 26,771.7%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22344 80,105.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554967 25,694.0%  
Other income Rs m2,9062 117,173.4%   
Total revenues Rs m251,460970 25,928.0%   
Gross profit Rs m37,07086 42,870.0%  
Depreciation Rs m12,44627 46,044.4%   
Interest Rs m1,4050 334,476.2%   
Profit before tax Rs m26,12562 42,472.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,84916 41,810.1%   
Profit after tax Rs m19,27745 42,713.3%  
Gross profit margin %14.98.9 166.8%  
Effective tax rate %26.226.6 98.5%   
Net profit margin %7.84.7 166.2%  
BALANCE SHEET DATA
Current assets Rs m214,599586 36,642.3%   
Current liabilities Rs m114,938430 26,745.3%   
Net working cap to sales %40.116.1 248.8%  
Current ratio x1.91.4 137.0%  
Inventory Days Days214 520.5%  
Debtors Days Days661,582 4.1%  
Net fixed assets Rs m176,668319 55,468.9%   
Share capital Rs m586319 183.7%   
"Free" reserves Rs m267,813-96 -279,378.9%   
Net worth Rs m268,399223 120,331.1%   
Long term debt Rs m6,19016 38,564.5%   
Total assets Rs m392,125904 43,369.0%  
Interest coverage x19.6147.5 13.3%   
Debt to equity ratio x00.1 32.0%  
Sales to assets ratio x0.61.1 59.2%   
Return on assets %5.35.0 104.7%  
Return on equity %7.220.2 35.5%  
Return on capital %10.025.9 38.7%  
Exports to sales %33.70-   
Imports to sales %15.30-   
Exports (fob) Rs m83,703NA-   
Imports (cif) Rs m38,060NA-   
Fx inflow Rs m85,4830-   
Fx outflow Rs m41,4470-   
Net fx Rs m44,0360-   
CASH FLOW
From Operations Rs m23,868-85 -28,095.9%  
From Investments Rs m-39,77891 -43,803.0%  
From Financial Activity Rs m18,144NA -4,320,023.8%  
Net Cashflow Rs m2,2985 42,235.3%  

Share Holding

Indian Promoters % 48.8 53.9 90.5%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 0.1 29,514.3%  
FIIs % 20.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 46.1 104.5%  
Shareholders   241,944 12,571 1,924.6%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs SYSCHEM (I).

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs SYSCHEM (I). Share Price Performance

Period Aurobindo Pharma SYSCHEM (I). S&P BSE HEALTHCARE
1-Day 1.82% 5.00% 1.18%
1-Month 5.96% 6.34% -0.75%
1-Year 113.07% 27.07% 61.82%
3-Year CAGR 7.78% 98.60% 18.16%
5-Year CAGR 7.18% 46.25% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the SYSCHEM (I). share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of SYSCHEM (I). the stake stands at 53.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of SYSCHEM (I)..

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

SYSCHEM (I). paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of SYSCHEM (I)..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.